Drug price history · CMS NADAC read 11 November 2026

What have pharmacies paid for Valsartan since 2013?

What pharmacies pay, not what you pay. Valsartan has 4 products in the CMS NADAC survey, 4 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Valsartan 160 MG Tablet: $3.21 per unit at the 2014 survey and $0.106 at 2026 (−97%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Valsartan4 products in NADAC
4products with a price history
  1. Valsartan has 4 products in the CMS NADAC survey, 4 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
  2. Between each product's first and latest year-end survey, 2 products cost pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
  3. 2 of the changes rest on fewer than 3 priced NDCs at one end and are marked thin: a median over one or two NDCs reflects which NDCs were priced as much as a price movement.
  4. This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.

Valsartan 160 MG Tablet

Generic

$3.21 per unit at the 2014 year-end survey (3 NDCs) and $0.106 at the 2026 survey (18 NDCs): −97%.

$0$3.212014: median $3.21 per unit, 3 NDCs priced2015: median $0.330 per unit, 19 NDCs priced2016: median $0.197 per unit, 20 NDCs priced2017: median $0.110 per unit, 22 NDCs priced2018: median $0.370 per unit, 17 NDCs priced2019: median $0.296 per unit, 14 NDCs priced2020: median $0.271 per unit, 14 NDCs priced2021: median $0.273 per unit, 16 NDCs priced2022: median $0.232 per unit, 16 NDCs priced2023: median $0.191 per unit, 17 NDCs priced2024: median $0.150 per unit, 19 NDCs priced2025: median $0.139 per unit, 19 NDCs priced2026: median $0.106 per unit, 18 NDCs priced2014201620182020202220242026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2014 (2014-12-31)$3.213
2015 (2015-12-30)$0.33019
2016 (2016-12-28)$0.19720
2017 (2017-12-27)$0.11022
2018 (2018-12-26)$0.37017
2019 (2019-12-25)$0.29614
2020 (2020-12-30)$0.27114
2021 (2021-12-29)$0.27316
2022 (2022-12-28)$0.23216
2023 (2023-12-27)$0.19117
2024 (2024-12-25)$0.15019
2025 (2025-12-31)$0.13919
2026 (2026-11-11)$0.10618

Valsartan 320 MG Tablet

Generic

$4.02 per unit at the 2014 year-end survey (2 NDCs) and $0.170 at the 2026 survey (14 NDCs): −96%, a thin comparison.

$0$4.022014: median $4.02 per unit, 2 NDCs priced2015: median $0.430 per unit, 15 NDCs priced2016: median $0.308 per unit, 18 NDCs priced2017: median $0.159 per unit, 21 NDCs priced2018: median $0.395 per unit, 16 NDCs priced2019: median $0.493 per unit, 11 NDCs priced2020: median $0.389 per unit, 11 NDCs priced2021: median $0.356 per unit, 13 NDCs priced2022: median $0.265 per unit, 14 NDCs priced2023: median $0.233 per unit, 15 NDCs priced2024: median $0.197 per unit, 16 NDCs priced2025: median $0.191 per unit, 15 NDCs priced2026: median $0.170 per unit, 14 NDCs priced2014201620182020202220242026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2014 (2014-12-31)$4.022
2015 (2015-12-30)$0.43015
2016 (2016-12-28)$0.30818
2017 (2017-12-27)$0.15921
2018 (2018-12-26)$0.39516
2019 (2019-12-25)$0.49311
2020 (2020-12-30)$0.38911
2021 (2021-12-29)$0.35613
2022 (2022-12-28)$0.26514
2023 (2023-12-27)$0.23315
2024 (2024-12-25)$0.19716
2025 (2025-12-31)$0.19115
2026 (2026-11-11)$0.17014

Valsartan 40 MG Tablet

Generic

$2.52 per unit at the 2014 year-end survey (2 NDCs) and $0.100 at the 2026 survey (19 NDCs): −96%, a thin comparison.

$0$2.522014: median $2.52 per unit, 2 NDCs priced2015: median $0.292 per unit, 14 NDCs priced2016: median $0.179 per unit, 16 NDCs priced2017: median $0.104 per unit, 18 NDCs priced2018: median $0.260 per unit, 14 NDCs priced2019: median $0.275 per unit, 11 NDCs priced2020: median $0.247 per unit, 11 NDCs priced2021: median $0.220 per unit, 16 NDCs priced2022: median $0.162 per unit, 17 NDCs priced2023: median $0.133 per unit, 19 NDCs priced2024: median $0.123 per unit, 20 NDCs priced2025: median $0.111 per unit, 20 NDCs priced2026: median $0.100 per unit, 19 NDCs priced2014201620182020202220242026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2014 (2014-12-31)$2.522
2015 (2015-12-30)$0.29214
2016 (2016-12-28)$0.17916
2017 (2017-12-27)$0.10418
2018 (2018-12-26)$0.26014
2019 (2019-12-25)$0.27511
2020 (2020-12-30)$0.24711
2021 (2021-12-29)$0.22016
2022 (2022-12-28)$0.16217
2023 (2023-12-27)$0.13319
2024 (2024-12-25)$0.12320
2025 (2025-12-31)$0.11120
2026 (2026-11-11)$0.10019

Valsartan 80 MG Tablet

Generic

$3.01 per unit at the 2014 year-end survey (3 NDCs) and $0.081 at the 2026 survey (17 NDCs): −97%.

$0$3.012014: median $3.01 per unit, 3 NDCs priced2015: median $0.320 per unit, 18 NDCs priced2016: median $0.181 per unit, 20 NDCs priced2017: median $0.090 per unit, 24 NDCs priced2018: median $0.219 per unit, 19 NDCs priced2019: median $0.266 per unit, 14 NDCs priced2020: median $0.263 per unit, 14 NDCs priced2021: median $0.233 per unit, 16 NDCs priced2022: median $0.186 per unit, 16 NDCs priced2023: median $0.155 per unit, 17 NDCs priced2024: median $0.122 per unit, 18 NDCs priced2025: median $0.124 per unit, 18 NDCs priced2026: median $0.081 per unit, 17 NDCs priced2014201620182020202220242026
year-end median across the NDCs pricedlowest to highest NDC
Year-end surveyMedian per unitLowest to highestNDCs priced
2014 (2014-12-31)$3.013
2015 (2015-12-30)$0.32018
2016 (2016-12-28)$0.18120
2017 (2017-12-27)$0.09024
2018 (2018-12-26)$0.21919
2019 (2019-12-25)$0.26614
2020 (2020-12-30)$0.26314
2021 (2021-12-29)$0.23316
2022 (2022-12-28)$0.18616
2023 (2023-12-27)$0.15517
2024 (2024-12-25)$0.12218
2025 (2025-12-31)$0.12418
2026 (2026-11-11)$0.08117

CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.

Where does Valsartan sit on the generic price cliff?

Valsartan 160 MG Tablet: the first generic approval in its Orange Book group is dated 2014. Its year-end acquisition cost in 2026 is 3% of its first observed year-end price (2014). The median matched product, 12 years after its first generic approval, is at 16% (the middle half runs from 6% to 34%), so this product is below that middle half.

0%25%50%75%100%0 years after the first generic approval: median 100%, middle half 100% to 100%, 79 products1 years after the first generic approval: median 95%, middle half 71% to 100%, 118 products2 years after the first generic approval: median 80%, middle half 49% to 99%, 135 products3 years after the first generic approval: median 64%, middle half 36% to 90%, 142 products4 years after the first generic approval: median 55%, middle half 25% to 84%, 154 products5 years after the first generic approval: median 46%, middle half 16% to 80%, 154 products6 years after the first generic approval: median 45%, middle half 16% to 87%, 154 products7 years after the first generic approval: median 40%, middle half 14% to 71%, 153 products8 years after the first generic approval: median 32%, middle half 8% to 65%, 131 products9 years after the first generic approval: median 28%, middle half 7% to 67%, 109 products10 years after the first generic approval: median 22%, middle half 5% to 53%, 90 products11 years after the first generic approval: median 21%, middle half 5% to 51%, 79 products12 years after the first generic approval: median 16%, middle half 6% to 34%, 48 products13 years after the first generic approval: median 19%, middle half 14% to 39%, 23 productsValsartan 160 MG Tablet, 0 years after the first generic approval: 100% of its first observed price, 3 NDCs pricedValsartan 160 MG Tablet, 1 years after the first generic approval: 10% of its first observed price, 19 NDCs pricedValsartan 160 MG Tablet, 2 years after the first generic approval: 6% of its first observed price, 20 NDCs pricedValsartan 160 MG Tablet, 3 years after the first generic approval: 3% of its first observed price, 22 NDCs pricedValsartan 160 MG Tablet, 4 years after the first generic approval: 12% of its first observed price, 17 NDCs pricedValsartan 160 MG Tablet, 5 years after the first generic approval: 9% of its first observed price, 14 NDCs pricedValsartan 160 MG Tablet, 6 years after the first generic approval: 8% of its first observed price, 14 NDCs pricedValsartan 160 MG Tablet, 7 years after the first generic approval: 9% of its first observed price, 16 NDCs pricedValsartan 160 MG Tablet, 8 years after the first generic approval: 7% of its first observed price, 16 NDCs pricedValsartan 160 MG Tablet, 9 years after the first generic approval: 6% of its first observed price, 17 NDCs pricedValsartan 160 MG Tablet, 10 years after the first generic approval: 5% of its first observed price, 19 NDCs pricedValsartan 160 MG Tablet, 11 years after the first generic approval: 4% of its first observed price, 19 NDCs pricedValsartan 160 MG Tablet, 12 years after the first generic approval: 3% of its first observed price, 18 NDCs priced024681012years since the first generic approval
median of 200 matched productsmiddle halfeach productValsartan 160 MG Tablet

This is a pattern in matched products. It does not say the first generic caused the fall, and it does not say this product's price will follow the median. See it with other drugs.

How many companies make Valsartan?

The FDA Orange Book lists 16 generic makers as marketed in its largest dosage form for Valsartan, and the first generic approval is dated 26 June 2014. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.

Where can you go from this record?

Open it in the check to search another drug, or see the CMS pharmacy pricing page for what NADAC measures. For who makes the generic and which patents are listed, see the generic competition check for Valsartan on OmniRx. To check whether a drug is in shortage, see the FDA drug shortages page.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the CMS pharmacy pricing page, year-end surveys 2013 to 2026 (latest 11 November 2026).